Production (Stage)
InspireMD, Inc.
NSPR
$2.53
$0.2510.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.03M | 7.01M | 6.82M | 6.57M | 6.48M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.03M | 7.01M | 6.82M | 6.57M | 6.48M |
| Cost of Revenue | 5.52M | 5.50M | 5.28M | 5.00M | 4.75M |
| Gross Profit | 1.51M | 1.51M | 1.54M | 1.57M | 1.73M |
| SG&A Expenses | 23.99M | 21.38M | 19.51M | 18.52M | 17.14M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.58M | 40.51M | 36.77M | 33.69M | 30.65M |
| Operating Income | -37.55M | -33.50M | -29.94M | -27.12M | -24.18M |
| Income Before Tax | -36.08M | -31.95M | -28.17M | -25.46M | -22.63M |
| Income Tax Expenses | 59.00K | 59.00K | 65.00K | 65.00K | 65.00K |
| Earnings from Continuing Operations | -36.14 | -32.01 | -28.24 | -25.52 | -22.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.14M | -32.01M | -28.24M | -25.52M | -22.69M |
| EBIT | -37.55M | -33.50M | -29.94M | -27.12M | -24.18M |
| EBITDA | -37.24M | -33.22M | -29.68M | -26.87M | -23.93M |
| EPS Basic | -0.79 | -0.78 | -0.75 | -0.74 | -0.76 |
| Normalized Basic EPS | -0.49 | -0.47 | -0.46 | -0.45 | -0.47 |
| EPS Diluted | -0.79 | -0.78 | -0.75 | -0.74 | -0.76 |
| Normalized Diluted EPS | -0.49 | -0.47 | -0.46 | -0.45 | -0.47 |
| Average Basic Shares Outstanding | 183.13M | 167.38M | 152.12M | 137.73M | 122.93M |
| Average Diluted Shares Outstanding | 183.13M | 167.38M | 152.12M | 137.73M | 122.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |